WHO plans Inclusion of environmental Aspects in GMP
Recommendation

20/21 October 2026
Understanding the Importance of GMP
The World Health Organization WHO has published a draft document on "Environmental Aspects of GMP: points to consider for manufacturers and inspectors in the prevention of antimicrobial resistance".
With this working document the WHO plans to include the topic of waste and wastewater management into their GMP Guidance: it "addresses the current needs for guidance on how GMPs should be implemented to waste and wastewater management for production of antimicrobials, with a focus on Critically Important Antimicrobials."
This initiative could raise concerns with national competent authorities and within industry. The underlying problem is that most active substances (APIs) are produced in countries with weak environmental legislation. An appropriate initiative would be advisable. The WHO therefore means well, but is perhaps wrong to link this to GMP. One will see what the feedback will be from those who have the World Health Organization's permission to do so.
The document entitled "Environmental Aspects of Good Manufacturing Practices: Points to consider for Manufacturers and Inspectors in the Prevention of antimicrobial Resistance" can be commented until 14 June.
Related GMP News
14.10.2026EU Pharma Package: Council Adopts New Rules
14.10.2026ICH Publishes New Training Material for Quality Guidelines
14.10.2026WHO issues Draft Guidance on Quality Risk Management
26.08.2026GMP and "Planned Deviations" - a Contradiction?
19.08.2026Why Root Cause Analysis is the Key to efficient CAPA
19.08.2026EMA updates Guideline on implementing the Shortage Prevention Plan


